Cargando…

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

BACKGROUND: COVID-19 is a viral respiratory disease caused by the severe acute respiratory syndrome-Coronavirus type 2 (SARS-CoV-2). Patients with this disease may be more prone to venous or arterial thrombosis because of the activation of many factors involved in it, including inflammation, platele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu, Wang, Jinglan, Liu, Chenxi, Su, Longxiang, Zhang, Dong, Fan, Junping, Yang, Yanli, Xiao, Meng, Xie, Jing, Xu, Yingchun, Li, Yongzhe, Zhang, Shuyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594996/ https://www.ncbi.nlm.nih.gov/pubmed/33121429 http://dx.doi.org/10.1186/s10020-020-00230-x

Ejemplares similares

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
por: Yang, Yang, et al.
Publicado: (2020)

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
por: Ruhwald, Morten, et al.
Publicado: (2009)

Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage
por: Niwa, Aichi, et al.
Publicado: (2016)

Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients
por: Eichhorn, Tanja, et al.
Publicado: (2023)

Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children
por: Li, Mengyao, et al.
Publicado: (2021)

CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats
por: Lang, Shan, et al.
Publicado: (2017)

Effects of 1-Methylcyclopropene (1-MCP) and Ethylene on Postharvest Lignification of Common Beans (Phaseolus vulgaris L)
por: Xie, Guofang, et al.
Publicado: (2020)

The Risk Factors for Weaning Failure of Mechanically Ventilated Patients With COVID-19: A Retrospective Study in National Medical Team Work
por: Zhao, Hua, et al.
Publicado: (2021)

Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU
por: Zhang, Dong, et al.
Publicado: (2020)

The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder
por: Dalgard, C, et al.
Publicado: (2017)

Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults
por: Hayney, Mary S., et al.
Publicado: (2017)

IP-10 Is a Potential Biomarker of Cystic Fibrosis Acute Pulmonary Exacerbations
por: Solomon, George M., et al.
Publicado: (2013)

Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma
por: Chang, Chen, et al.
Publicado: (2021)

Plasma CXCL8 and MCP-1 as biomarkers of latent tuberculosis infection
por: Selvavinayagam, Sivaprakasam T, et al.
Publicado: (2023)

MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease
por: Fang, Chun, et al.
Publicado: (2023)

Risk factors for mortality due to COVID-19 in intensive care units: a single-center study
por: Chen, Yu, et al.
Publicado: (2021)

Protecting IP of Deep Neural Networks with Watermarking: A New Label Helps
por: Zhong, Qi, et al.
Publicado: (2020)

Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity
por: Haroun, Riham Abdel-Hamid, et al.
Publicado: (2021)

Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock
por: Tian, Rui, et al.
Publicado: (2019)

MCP Analysis on ALPHA
por: CHIAO, Chia-Hao
Publicado: (2014)

E=mcp2s /
por: Bodanis, David
Publicado: (2000)

MIP-1α and MCP-1 as salivary biomarkers in periodontal disease
por: Nisha, K.J., et al.
Publicado: (2018)

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19
por: Hashimoto, Shoji, et al.
Publicado: (2021)

Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
por: Zhang, Dong, et al.
Publicado: (2021)

Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019
por: Wang, Guo-Lin, et al.
Publicado: (2021)

Optimization design of the large area Dynode-MCP-PMT
por: Chen, Lin, et al.
Publicado: (2022)

Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis
por: Kim, Song Yee, et al.
Publicado: (2018)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
por: Lunardi, Serena, et al.
Publicado: (2015)

The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-κB, MCP-1 and MMP-9
por: Zhang, Xintong, et al.
Publicado: (2017)

Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis
por: Qiu, Xia, et al.
Publicado: (2019)

Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population
por: Wang, Sen, et al.
Publicado: (2012)

Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV
por: You, Chan Ran, et al.
Publicado: (2011)

Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children than IFNγ?
por: Whittaker, Elizabeth, et al.
Publicado: (2008)

Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle
por: Parsons, Sven D. C., et al.
Publicado: (2016)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Effect of herba centellae on the expression of HGF and MCP-1
por: ZHANG, ZHU, et al.
Publicado: (2013)

An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012)

Age increases MCP‐1 level in association with bariatric surgery operating time and metabolic risk severity
por: Malin, S. K., et al.
Publicado: (2017)

Structure of mouse IP-10, a chemokine
por: Jabeen, Talat, et al.
Publicado: (2008)

Status of the Timepix MCP-HPD development
por: Tick, T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r8b3r8godppi2c2b2kf73pkfqg